The cells were first incubated in a nonspecific blocking medium of 4% normal goat serum and 1% BSA in PBS, pH 7.2, for one hour at 4#{176}C. The same medium without goat serum was then used to make appropriate dilutions of the primary antibody B4, and samples of cells from both patients were then incubated in antibody for two hours at room temperature. After three washes with PBS, the cell samples were incubated for a further hour at room temperature in the second antibody, a 1 :50 dilution of goat antimouse serum conjugated to I 5-nm colloidal gold particles (Janssen Pharmaceuticals, Beerse, Belgium) in the same diluent as that used for the primary antibody.
The cells were then washed three times before processing for electron microscopy as described in the previous paragraph. T cell receptor genes were examined by using a 2.5-kb SacI/ EcoRI fragment containing the C fi 1 and C fi 2 constant region gene segments of the human T cell receptor'9 (kindly provided by Dr A. Tunnacliffe).'9
The c-ets I probe #{176}was a 5.4-kb EcoRI fragment containing the human c-ets 1 oncogene (kindly provided by Dr D. Stehelin).
After hybridization, the filters were washed under conditions of high stringency and then exposed to Kodak X-AR 5 film in the presence of intensifying screens for three to seven days at -70#{176}C. of the blasts coexpressed both markers (Fig 1) . For Nor did we find any evidence for T cell receptor f9 chain rearrangement in any case. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
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